COMMERZBANK AKTIENGESELLSCHAFT /FI
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 852933
FRANKFURT, 2M
Position in REGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$315,511
-$100,941 QoQ
Shares Held
506
-6.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#927
of 1,322 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026COMMERZBANK AKTIENGESELLSCHAFT /FI holds $5,329,032 across 4 Biotechnology names. REGN ranks #4 (5.9% of the industry book) .
All Filings in REGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $315,511 | 506 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $416,452 | 539 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $446,140 | 578 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $324,992 | 578 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $315,525 | 601 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $381,172 | 601 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $428,110 | 601 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $422,598 | 402 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $242,787 | 231 | Shares | Sole | 2024-07-22 | |
| 2020-03-31 | $3,069,879 | 6,287 | Shares | Sole | 2024-10-03 | |
| No filing history on record for this holder in this stock. | ||||||